High rates of midazolam injection and associated harms in Bangkok, Thailand
Autor: | Evan Wood, Lianping Ti, Paisan Suwannawong, Karyn Kaplan, Kanna Hayashi, Thomas Kerr |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
business.industry Medicine (miscellaneous) Poison control Odds ratio Logistic regression Occupational safety and health Confidence interval Heroin Psychiatry and Mental health Anesthesia Internal medicine mental disorders Injury prevention medicine Midazolam business medicine.drug |
Zdroj: | Addiction. 108:944-952 |
ISSN: | 0965-2140 |
DOI: | 10.1111/add.12094 |
Popis: | AIMS: To identify the prevalence and correlates of midazolam injection among injecting drug users in Thailand. DESIGN: Serial cross-sectional mixed-methods study. SETTING: Bangkok, Thailand. PARTICIPANTS: 435 adults who had injected drug(s) in the past six months were recruited through peer outreach and word-of-mouth in Bangkok in 2011. MEASUREMENTS: Multivariable logistic regression was used to analyze self-reported data collected through an interviewer-administered survey in July-October 2011 (n=435). Additionally, qualitative data were collected in June-July 2009 (n=10) and analyzed to explore the health problems attributable to midazolam injection. FINDINGS: Among 435 survey participants, the prevalence of daily midazolam injection in the past six months was 37.0% (95% Confidence Interval: 32-42). While 75.8% of the daily midazolam injectors identified heroin as their drug of choice, 91.8% of these individuals reported substituting heroin with midazolam when heroin was unavailable. In multivariable analyses, daily midazolam injection was associated with femoral vein injection (Adjusted Odds Ratio [AOR] = 4.48), polydrug use (AOR = 4.94), daily heroin injection (AOR = 3.25), binge use (AOR = 1.75), and perceived increase in policing pressure (AOR = 1.95) (all p Language: en |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |